반응식
I[C:2]1[CH:7]=[CH:6][N:5]=[CH:4][C:3]=1[NH:8][C:9](=[O:14])[C:10]([CH3:13])([CH3:12])[CH3:11].[Cl:15][C:16]1[CH:17]=[CH:18][C:19]([CH3:25])=[C:20](B(O)O)[CH:21]=1>CCCCCCC.CCOC(C)=O>[Cl:15][C:16]1[CH:21]=[CH:20][C:19]([CH3:25])=[C:18]([C:2]2[CH:7]=[CH:6][N:5]=[CH:4][C:3]=2[NH:8][C:9](=[O:14])[C:10]([CH3:13])([CH3:12])[CH3:11])[CH:17]=1참가 물질
4
실험 절차
The title compound was prepared in analogy to example 72, from N-(4-iodo-pyridin-3-yl)-2,2-dimethyl-propionamide (CAS RN 113975-32-9) and 5-chloro-2-methylphenylboronic acid (CAS RN 148839-33-2) and using a gradient of n-heptane:EtOAc (100:0 to 0:100). Light yellow solid (99%). MS (ESI): m/z=303.126 [M+H]+.
출처 및 근거
- ORD 기록
- ord-d620593104e74924b11517bf91f926ed
- 출처 데이터셋
- uspto-grants-2015_03
- 특허 번호
- US08987307B2
연결된 노트
불러오는 중…